Up-regulation of NKG2D ligands by AML cells to increase sensitivity to NK cells: The tumour might strike back. Comment on "Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis" by Rohner et al. [Leuk Res 2007;31:1393-402]

Jacques Zimmer; Tatiana Michel; Emmanuel Andrès; François Hentges

doi:10.1016/j.leukres.2007.09.001

Up-regulation of NKG2D ligands by AML cells to increase sensitivity to NK cells: The tumour might strike back. Comment on "Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis" by Rohner et al. [Leuk Res 2007;31:1393-402]

Jacques Zimmer^*, Tatiana Michel, Emmanuel Andrès, François Hentges

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

3 Citations (Scopus)

Original language	English
Pages (from-to)	676-677
Number of pages	2
Journal	Leukemia Research
Volume	32
Issue number	4
DOIs	https://doi.org/10.1016/j.leukres.2007.09.001
Publication status	Published - Apr 2008

Access to Document

10.1016/j.leukres.2007.09.001

Cite this

Zimmer, J., Michel, T., Andrès, E., & Hentges, F. (2008). Up-regulation of NKG2D ligands by AML cells to increase sensitivity to NK cells: The tumour might strike back. Comment on "Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis" by Rohner et al. [Leuk Res 2007;31:1393-402]. Leukemia Research, 32(4), 676-677. https://doi.org/10.1016/j.leukres.2007.09.001

Zimmer, Jacques ; Michel, Tatiana ; Andrès, Emmanuel et al. / Up-regulation of NKG2D ligands by AML cells to increase sensitivity to NK cells : The tumour might strike back. Comment on "Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis" by Rohner et al. [Leuk Res 2007;31:1393-402]. In: Leukemia Research. 2008 ; Vol. 32, No. 4. pp. 676-677.

@article{54cc3ef7120543c188601fd016066c1d,

title = "Up-regulation of NKG2D ligands by AML cells to increase sensitivity to NK cells: The tumour might strike back. Comment on {"}Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis{"} by Rohner et al. [Leuk Res 2007;31:1393-402]",

author = "Jacques Zimmer and Tatiana Michel and Emmanuel Andr{\`e}s and Fran{\c c}ois Hentges",

note = "Funding Information: The work of the “Laboratoire d{\textquoteright}Immunog{\'e}n{\'e}tique-Allergologie” is supported by institutional grants from the “CRP-Sant{\'e} de Luxembourg”. ",

year = "2008",

month = apr,

doi = "10.1016/j.leukres.2007.09.001",

language = "English",

volume = "32",

pages = "676--677",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Ltd.",

number = "4",

}

Zimmer, J, Michel, T, Andrès, E & Hentges, F 2008, 'Up-regulation of NKG2D ligands by AML cells to increase sensitivity to NK cells: The tumour might strike back. Comment on "Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis" by Rohner et al. [Leuk Res 2007;31:1393-402]', Leukemia Research, vol. 32, no. 4, pp. 676-677. https://doi.org/10.1016/j.leukres.2007.09.001

Up-regulation of NKG2D ligands by AML cells to increase sensitivity to NK cells: The tumour might strike back. Comment on "Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis" by Rohner et al. [Leuk Res 2007;31:1393-402]. / Zimmer, Jacques; Michel, Tatiana; Andrès, Emmanuel et al.
In: Leukemia Research, Vol. 32, No. 4, 04.2008, p. 676-677.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Up-regulation of NKG2D ligands by AML cells to increase sensitivity to NK cells

T2 - The tumour might strike back. Comment on "Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis" by Rohner et al. [Leuk Res 2007;31:1393-402]

AU - Zimmer, Jacques

AU - Michel, Tatiana

AU - Andrès, Emmanuel

AU - Hentges, François

N1 - Funding Information: The work of the “Laboratoire d’Immunogénétique-Allergologie” is supported by institutional grants from the “CRP-Santé de Luxembourg”.

PY - 2008/4

Y1 - 2008/4

UR - http://www.scopus.com/inward/record.url?scp=39149117679&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2007.09.001

DO - 10.1016/j.leukres.2007.09.001

M3 - Letter

C2 - 17920678

AN - SCOPUS:39149117679

SN - 0145-2126

VL - 32

SP - 676

EP - 677

JO - Leukemia Research

JF - Leukemia Research

IS - 4

ER -

Zimmer J, Michel T, Andrès E, Hentges F. Up-regulation of NKG2D ligands by AML cells to increase sensitivity to NK cells: The tumour might strike back. Comment on "Differentiation-promoting drugs up-regulate NKG2D ligand expression and enhance the susceptibility of acute myeloid leukemia cells to natural killer cell-mediated lysis" by Rohner et al. [Leuk Res 2007;31:1393-402]. Leukemia Research. 2008 Apr;32(4):676-677. doi: 10.1016/j.leukres.2007.09.001

Access to Document

Other files and links

Cite this